日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial

Sacituzumab Govitecan 与多西他赛治疗转移性非小细胞肺癌的患者报告症状和生活质量:3 期随机 EVOKE-01 试验

Reinmuth, Niels; Couraud, Sébastien; Paz-Ares, Luis; Garassino, Marina Chiara; Baijal, Shobhit; Daniel, Davey; Garrido, Pilar; Kato, Terufumi; Percent, Ivor; Rittmeyer, Achim; Parra, Hector Soto; Mekan, Sabeen; Patel, Mira; Radford, Matthew; Zhang, Eric; Pelligra, Christopher G; Guo, Shien; Felip, Enriqueta

Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer

EVOKE-01 研究(sacituzumab govitecan 与多西他赛治疗非小细胞肺癌患者的比较)的简明语言摘要

Paz-Ares, Luis G; Juan-Vidal, Oscar; Mountzios, Giannis S; Felip, Enriqueta; Reinmuth, Niels; de Marinis, Filippo; Girard, Nicolas; Patel, Vipul M; Takahama, Takayuki; Owen, Scott P; Reznick, Douglas M; Badin, Firas B; Cicin, Irfan; Mekan, Sabeen; Patel, Riddhi; Zhang, Eric; Karumanchi, Divyadeep; Garassino, Marina Chiara

Trop-2 expression in non-small cell lung cancer.

非小细胞肺癌中Trop-2的表达

Kuo Peiwen, Elboudwarej Emon, Zavodovskaya Marianna, Lin Kai-Wen, Lee Chingwei V, Diehl Lauri, Patel Jilpa, Mekan Sabeen, Jürgensmeier Juliane M

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Sacituzumab Govitecan 与多西他赛治疗既往接受过治疗的晚期或转移性非小细胞肺癌:随机、开放标签 III 期 EVOKE-01 研究

Paz-Ares, Luis G; Juan-Vidal, Oscar; Mountzios, Giannis S; Felip, Enriqueta; Reinmuth, Niels; de Marinis, Filippo; Girard, Nicolas; Patel, Vipul M; Takahama, Takayuki; Owen, Scott P; Reznick, Douglas M; Badin, Firas B; Cicin, Irfan; Mekan, Sabeen; Patel, Riddhi; Zhang, Eric; Karumanchi, Divyadeep; Garassino, Marina Chiara

Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer

Sacituzumab Govitecan治疗晚期实体瘤患者的疗效和安全性(TROPiCS-03):晚期子宫内膜癌患者的分析

Santin, Alessandro D; Corr, Bradley R; Spira, Alexander; Willmott, Lyndsay; Butrynski, James; Tse, Ka Yu; Patel, Jilpa; Mekan, Sabeen; Wu, Tia; Lin, Kai-Wen; Kuo, Peiwen; Dumbrava, Ecaterina E

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

纳武利尤单抗联合伊匹木单抗对比舒尼替尼一线治疗晚期肾细胞癌:一项随机、对照、3期试验的疗效和安全性结果的长期随访

Motzer, Robert J; Rini, Brian I; McDermott, David F; Arén Frontera, Osvaldo; Hammers, Hans J; Carducci, Michael A; Salman, Pamela; Escudier, Bernard; Beuselinck, Benoit; Amin, Asim; Porta, Camillo; George, Saby; Neiman, Victoria; Bracarda, Sergio; Tykodi, Scott S; Barthélémy, Philippe; Leibowitz-Amit, Raya; Plimack, Elizabeth R; Oosting, Sjoukje F; Redman, Bruce; Melichar, Bohuslav; Powles, Thomas; Nathan, Paul; Oudard, Stéphane; Pook, David; Choueiri, Toni K; Donskov, Frede; Grimm, Marc-Oliver; Gurney, Howard; Heng, Daniel Y C; Kollmannsberger, Christian K; Harrison, Michael R; Tomita, Yoshihiko; Duran, Ignacio; Grünwald, Viktor; McHenry, M Brent; Mekan, Sabeen; Tannir, Nizar M

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

纳武利尤单抗联合伊匹木单抗对比舒尼替尼治疗晚期肾细胞癌

Motzer, Robert J; Tannir, Nizar M; McDermott, David F; Arén Frontera, Osvaldo; Melichar, Bohuslav; Choueiri, Toni K; Plimack, Elizabeth R; Barthélémy, Philippe; Porta, Camillo; George, Saby; Powles, Thomas; Donskov, Frede; Neiman, Victoria; Kollmannsberger, Christian K; Salman, Pamela; Gurney, Howard; Hawkins, Robert; Ravaud, Alain; Grimm, Marc-Oliver; Bracarda, Sergio; Barrios, Carlos H; Tomita, Yoshihiko; Castellano, Daniel; Rini, Brian I; Chen, Allen C; Mekan, Sabeen; McHenry, M Brent; Wind-Rotolo, Megan; Doan, Justin; Sharma, Padmanee; Hammers, Hans J; Escudier, Bernard